SNOA icon

Sonoma Pharmaceuticals
SNOA

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $71.5K invested in Sonoma Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$36.8K
2
+$25K
3
+$1.78K
4
Bank of America
Bank of America
North Carolina
+$6

Top Sellers

1
-$34.1K
2
-$2.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
$36.8K
HF
2
HRT Financial
New York
$25K
UBS Group
3
UBS Group
Switzerland
$4.06K
TRCT
4
Tower Research Capital (TRC)
New York
$3.17K
Citigroup
5
Citigroup
New York
$1.78K
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$302
BlackRock
7
BlackRock
New York
$247
US Bancorp
8
US Bancorp
Minnesota
$55
Bank of America
9
Bank of America
North Carolina
$32
AF
10
Allworth Financial
California
$12
Morgan Stanley
11
Morgan Stanley
New York
$9